Shunt lock therapy with micafungin to treat shunt-associated Candida albicans meningitis in an infant.
(2016) Journal of Antimicrobial Chemotherapy — Vol. 71, n° 7, p. 2060-2061 (2016)
Files
2016_Auriti_J_Antimicrob_Chemother.pdf
Open Access - Adobe PDF
- 93.06 KB
Details
- Authors
- Abstract
- Sir, Shunt-associated fungal infections are currently treated with systemic antifungal therapy and shunt replacement, as fungi inside the lumen form a biofilm in which microorganisms are protected from antifungal therapy. This is the reason why CSF cultures may remain positive despite optimal therapy. [...]
- Affiliations
Bambino Gesù Children’s Hospital – (Italy) Rome Department of Medical and Surgical Neonatology
Citations
Auriti, C., Piersigilli, F., Ronchetti, M. P., Campi, F., Amante, P. G., Falcone, M., & Goffredo, B. M. (2016). Shunt lock therapy with micafungin to treat shunt-associated Candida albicans meningitis in an infant. Journal of Antimicrobial Chemotherapy, 71(7), 2060-2061. https://doi.org/10.1093/jac/dkw072 (Original work published 2016)